DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

NxStage Medical (NASDAQ: NXTM)

18.09 -0.19 (-1.01%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NXTM $18.09 -1.01%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $18.24
Previous Close $18.28
Daily Range $17.90 - $18.26
52-Week Range $9.39 - $18.59
Market Cap $1.1B
P/E Ratio -45.69
Dividend (Yield) $0.00 (0.0%)
Volume 462,353
Average Daily Volume 548,572
Current FY EPS -$0.41




Healthcare Information Services

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website:

News & Commentary Rss Feed

Why NxStage Medical Inc. Stock Surged Higher

Medical device maker NxStage filters out the pessimists and rockets higher by as much as 13% after reporting better-than-expected third-quarter earnings results and lifting its full-year sales forecast.

Health Care Sector Update for 12/18/2014: CMRX,CTRV,OVAS,RWLK,NXTM

Health Care Sector Update for 12/18/2014: TTPH,AMDA,RWLK,NXTM

Insider Trading Alert - VYFC, CI And NXTM Traded By Insiders

Insider Trading Alert - THOR, NXTM And AAON Traded By Insiders

NxStage Medical (NXTM) Upgraded From Sell to Hold

NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog

NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog

Update: NxStage Medical Q3 2014 Earnings

How to Uncover Institutional Buying - Screen of the Week

NxStage Medical's (NXTM) CEO Jeff Burbank on Q3 2014 Results - Earnings Call Transcript

See More NXTM News...

NXTM's Top Competitors

NXTM $18.09 (-1.01%)
Current stock: NXTM
$0.00 (0.00%)
Current stock:
MDT $74.62 (-0.01%)
Current stock: MDT
COV $102.90 (-0.31%)
Current stock: COV